Jade Biosciences, Inc. (JBIO) has 1 open-market insider trade by 1 insider since 2025. The most active filer is Tom Frohlich, Chief Executive Officer.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Tom Frohlich | Chief Executive Officer | — | 1 | $44K | 2026-02-12 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Tom Frohlich | Chief Executive Officer | Buy | $44K | 2025-05-16 |
Companies that share insiders with JBIO, and sector peers with recent insider buying. Related by who files, not by how the stocks move.